Prostate cancer research
Prostate cancer is the most frequently diagnosed cancer in Canadian males, and is the third most common cause of death due to cancer in men (after lung and colorectal cancer).
The Canadian Cancer Society is working hard to help control this disease, which affects thousands of men and their families, and causes concern among millions more.
We fund a broad range of excellent prostate cancer research projects every year that examine important questions about this disease:
- why does it start and how does it spread
- ways to prevent prostate cancer
- new and better ways to diagnose and treat the disease.
Among our current prostate cancer research this year:
- Research aimed at developing an advanced molecular test that will tell doctors whether patients have an aggressive form of prostate cancer and, ultimately, helping to determine the best treatment
-
A study to find out how hormone therapy for prostate cancer affects a patient’s quality of life – which will provide important information to patients and doctors considering hormone therapy and may lead to ways to prevent or reverse some of these side effects.
-
Research looking at how to improve brachytherapy – a promising prostate cancer treatment approach using tiny radioactive seeds which are implanted in the tumour – that will lead to the development of more precise ways of treating patients while reducing side effects.
Read about some of the latest prostate cancer discoveries made by Society-funded researchers
Dr Michael Pollak finds weight linked to prostate cancer death
Other Society resources
More information about prostate cancer screening
Search our database of all research projects we’re funding this year.
Last modified on:
26 March 2010
Back to top